Proteome Sciences (GB:PRM) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Proteome Sciences has reported a dip in revenues and gross profit in H1 2024 compared to the previous year but anticipates a resurgence in orders following the launch of their new TMTpro 35plex tags. The company is optimistic about returning to growth with increased orders in Q3 and the development of their innovative plexDIA tags, which are entering licensing discussions. Additionally, their U.S. lab has begun delivering projects, and a CEO transition is underway with Dr. Mariola Soehngen stepping down in January 2025.
For further insights into GB:PRM stock, check out TipRanks’ Stock Analysis page.
